These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9722763

  • 1. Urological consequences of incomplete cord lesions in patients with myelomeningocele.
    Keshtgar AS, Rickwood AM.
    Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763
    [Abstract] [Full Text] [Related]

  • 2. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F, Capolicchio JP, Jednak R, El Sherbiny M.
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [Abstract] [Full Text] [Related]

  • 3. Incidence of normal micturition in myelomeningocele patients.
    Reiner I, Jones M, Donnell S, Rickwood AM.
    Arch Dis Child; 1992 May; 67(5):640-1. PubMed ID: 1599305
    [Abstract] [Full Text] [Related]

  • 4. [Renal outcome in myelodysplastic patients with untreated, risky vesico-sphincter dysfunction].
    Romero Maroto J, Perales Cabanas L, Rodríguez Luna JM, Fernández Fernández A, Escudero Barrilero A.
    Actas Urol Esp; 1989 May; 13(5):357-62. PubMed ID: 2596354
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
    Marte A, Vessella A, Cautiero P, Romano M, Borrelli M, Noviello C, Del Gado R, Parmeggiani P.
    Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
    [Abstract] [Full Text] [Related]

  • 6. Urodynamic dysfunction in walking myelodysplastic children.
    Dator DP, Hatchett L, Dyro FM, Shefner JM, Bauer SB.
    J Urol; 1992 Aug; 148(2 Pt 1):362-5. PubMed ID: 1635136
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
    Kuo HC.
    BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
    [Abstract] [Full Text] [Related]

  • 8. Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder in children: a good alternative.
    Neel KF.
    J Urol; 2010 Jul; 184(1):315-8. PubMed ID: 20488484
    [Abstract] [Full Text] [Related]

  • 9. Urological outcome after myelomeningocele: 20 years of follow-up.
    Thorup J, Biering-Sorensen F, Cortes D.
    BJU Int; 2011 Mar; 107(6):994-9. PubMed ID: 20860652
    [Abstract] [Full Text] [Related]

  • 10. Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder.
    Khoury AE, Dave S, Peralta-Del Valle MH, Braga LH, Lorenzo AJ, Bägli D.
    BJU Int; 2008 Jan; 101(2):223-6. PubMed ID: 17970790
    [Abstract] [Full Text] [Related]

  • 11. Vesico-ureteral reflux in children with spina bifida and detrusor-sphincter dyssynergia.
    van Gool JD.
    Contrib Nephrol; 1984 Jan; 39():221-37. PubMed ID: 6744873
    [No Abstract] [Full Text] [Related]

  • 12. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele.
    Yu WR, Kuo HC.
    Int Urol Nephrol; 2022 Aug; 54(8):1815-1824. PubMed ID: 35608803
    [Abstract] [Full Text] [Related]

  • 13. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty.
    Vainrib M, Reyblat P, Ginsberg DA.
    Neurourol Urodyn; 2013 Mar; 32(3):250-3. PubMed ID: 22965686
    [Abstract] [Full Text] [Related]

  • 14. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.
    Corona LE, Lee T, Marchetti K, S Streur C, Ivancic V, Kraft KH, Bloom DA, Wan J, Park JM.
    J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele.
    Hernandez RD, Hurwitz RS, Foote JE, Zimmern PE, Leach GE.
    J Urol; 1994 Nov; 152(5 Pt 1):1582-5. PubMed ID: 7933209
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic treatment for urinary incontinence in children with a congenital neuropathic bladder.
    Silveri M, Capitanucci ML, Mosiello G, Broggi G, De Gennaro M.
    Br J Urol; 1998 Nov; 82(5):694-7. PubMed ID: 9839585
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of urinary incontinence of neurologic origin in children and adolescents].
    Mollard P, Meunier P, Berard C, Henriet M.
    J Urol (Paris); 1984 Nov; 90(3):227-36. PubMed ID: 6491360
    [Abstract] [Full Text] [Related]

  • 19. Management of myelomeningocele.
    Kaplan WE.
    Urol Clin North Am; 1985 Feb; 12(1):93-101. PubMed ID: 3883627
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, van Gool JD.
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.